Catalyst
Four analysts rate CTRA as Buy and one rates it as Strong Buy, reflecting broad institutional optimism.
CTRA demonstrates strong fundamentals with favorable metrics for asset-to-market value, revenue-to-market value, net income-to-revenue, and inventory turnover.
Risk
The company faces profitability valuation concerns indicated by a negative PB-ROE factor and carries a high long-term debt to working capital ratio.
Net fund flow trends are negative, driven by outflows from extra-large orders despite inflows from smaller investors.
Generated at21:3103/25/2026by
Aime